Reilly M T, Charles M
E. I. du Pont de Nemours & Company, Wilmington, Delaware.
Bioprocess Technol. 1990;6:243-91.
Commercialization of the products of biotechnology will require a continued emphasis on bioprocess design and scale-up. The use of process automation and control will help to meet the specifications of quality, safety, and cost. In the past, the application of process monitoring and control to biological processes has been limited by the availability of suitable sensors. New developments have combined the tools of microelectronics and molecular biology to address some of these limitations. Continued developments in this area will require close cooperation between microbiologists and process engineers to best apply these new tools. A general understanding of the concepts of process control, as they relate to biological processes, will contribute to that cooperation.
生物技术产品的商业化将需要持续重视生物过程设计和放大。过程自动化与控制的应用将有助于满足质量、安全和成本方面的规范要求。过去,过程监测与控制在生物过程中的应用因合适传感器的可用性而受到限制。新的发展将微电子学和分子生物学工具结合起来,以解决其中一些限制。该领域的持续发展将需要微生物学家和过程工程师密切合作,以最佳地应用这些新工具。对与生物过程相关的过程控制概念有一个总体了解,将有助于这种合作。